Expression of Human Endogenous Retroviruses (HERVs) in Breast Cancer: A Transcriptomic Study
By: D. Bartzi, A. Philippou, I. Tsatsou and M. Koutsilieris
References
- Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23.
- Giaquinto AN, Sung H, Newman LA, et al. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74(5):477–495.
- Merrill RM, Gibbons IS. Inequality in female breast cancer relative survival rates between white and black women in the United States. J Racial Ethn Health Disparities. 2024;1–10.
- Zhang S, Xiao X, Yi Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Ther. 2024;9:149.
- Xiong X, Zheng LW, Ding Y, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2024; 10:49.
- Mao J, Zhang Q, Cong YS. Human endogenous retroviruses in development and disease. Comput Struct Biotechnol J. 2021;19:5978-5986.
- Geis FK, Goff SP. Silencing and transcriptional regulation of endogenous retroviruses: an overview. Viruses. 2020;12(8):884.
- Lemaître C, Tsang J, Bireau C, et al. A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion. PLoS Pathog. 2017;13(1):e1006451.
- Xue B, Sechi I.A, Kelvin DJ. Human endogenous retrovirus K (HML-2) in health and disease. Front Microbiol. 2020;11:1690.
- Dervan E, Bhattacharyya DD, McAuliffe JD, et al. Ancient adversary - HERV-K (HML-2) in cancer. Front Oncol. 2021;11:658489.
- Subramanian RP, Wildschutte JH, Russo C, et al. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 2011;8:90.
- Montesion M, Williams ZH, Subramanian RP, et al. Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites. Retrovirology. 2018;15:57.
- National Center for Biotechnology Information (NCBI). The Sequence Read Archive (SRA) [Internet]. Bethesda (MD): NCBI; [cited 2024]. Available from: https://www.ncbi.nlm.nih.gov/sra
- Subramanian I, Verma S, Kumar S, et al. Multi-omics data integration, interpretation, and its application. Bioinform Biol Insights. 2020;14:1177932219899051.
- Belshaw R, Pereira V, Katzourakis A, et al. Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci USA. 2004;101(14):4894-4899.
- BEDTools. getfasta [Internet], [cited 2024], Available from: https://bedtools.readthedocs.io/en/latest/content/tools/get-fasta.html
- Bartzi D. Human endogenous retroviruses (HERVs) transcriptomics in human breast cancer [Master’s thesis]. Athens: National and Kapodistrian University of Athens; 2021. Available from: https://pergamos.lib.uoa.gr/uoa/dl/frontend/en/browse/2938645#contents
- Integrative Genomics Viewer (IGV) [Internet]. [cited 2024]. Available from: https://igv.org/
- Costa B. Vale N. Exploring HERV-K (HML-2) influence in cancer and prospects for therapeutic interventions. Int J Mol Sci. 2023;24(19):14631.
- Johanning GL, Malouf GG, Zheng X, et al. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype. Sci Rep. 2017;7:41960.
- Rivas SR, Valdez MJM, Govindarajan V, et al. The role of HERV-K in cancer stemness. Viruses. 2022;14(9):2019.
- Burn A, Roy F, Freeman M, et al. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues. PLoS Biol. 2022;20(10):e3001826.
- Cherkasova EA, Chen L, Childs RW. Mechanistic regulation of HERV activation in tumors and implications for translational research in oncology. Front Cell Infect Microbiol. 2024;14:1358470.
- Wei Y, Wei H, Wtei Y, et al. Screening and identification of human endogenous retrovirus-K mRNAs for breast cancer through integrative analysis of multiple datasets. Front Oncol. 2022;12:820883.
- Wang-Johanning F, Li M, Esteva FJ, et al. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer. 2014; 134(3):587-595.
- Simula ER, Jasemi S, Cossu D, et al. Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines. 2025;13(4):415.
- Bannert N, Hofmann H, Block A, et al. HERVs new role in cancer: from accused perpetrators to cheerful protectors. Front Microbiol. 2018;9:178.
- Stricker E, Peckham-Gregory EC, Scheurer ME. HERVs and cancer – a comprehensive review of the relationship of human endogenous retroviruses and human cancers. Biomedicines. 2023;11(3):936.
- Molla G, Bitew M. Revolutionizing personalized medicine: synergy with multi-omics data generation, main hurdles, and future perspectives. Biomedicines. 2024; 12(12):2750.
- Logotheti S, Stiewe T, Georgakilas AG. The rale of human endogenous retroviruses in cancer immunotherapy of the post- COVID-19 world. Cancers. 2023;15(21):5321.
DOI: https://doi.org/10.2478/amb-2026-0071 | Journal eISSN: 2719-5384 (formerly 0324-1750) | Journal ISSN: 0324-1750
Language: English
Page range: 39 - 47
Submitted on: Dec 13, 2025
Accepted on: May 15, 2025
Published on: Sep 14, 2026
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 D. Bartzi, A. Philippou, I. Tsatsou, M. Koutsilieris, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.